EAPM believes that with an ageing population across the EU, and a longer life expectancy, more and more money will necessarily be spent on health, including a larger proportion of national budgets on up-to-the-minute education/training and jobs in the health sector. This, there is a need for much more efficient use of limited resources.
Regulators must take it possible to allow patients early access to novel and efficient treatment. Together we can transform our healthcare system into one that delivers the best care patients, empowers them, put research and innovation at their service, and gives the best possible value.
STEPs stands for Specialised Treatment for Europe's Patients by engaging with the new legislature of MEPs via the publication of its Briefing Document of MEPs and the setting up of a STEPs MEPs Interest Group.